Risks and outcomes of adenovirus disease in pediatric hematopoietic stem cell transplant recipients-Comparison of current antiviral treatment options.

Sanya J ThomasRebecca T YoungWilliam J SteinbachDebra J Lugo

Published in: Transplant infectious disease : an official journal of the Transplantation Society (2020)

Pediatric UCT recipients are at a higher risk for ADVd. Antiviral therapy was not associated with an earlier resolution of ADVd, even in patients with higher disease burden.

Keyphrases

hematopoietic stem cell
stem cells
single molecule
type diabetes
human health
adipose tissue
cell therapy
glycemic control
smoking cessation